149 related articles for article (PubMed ID: 37150609)
1. In vitro efficacy of cephamycins against multiple extended-spectrum β-lactamase-producing Klebsiella pneumoniae, Proteus mirabilis, and Enterobacter cloacae isolates from dogs and cats.
Kusumoto M; Kanao Y; Narita H; Jitsuiki M; Iyori K; Tsunoi M; Tsuyuki Y; Torii K; Harada K
J Vet Med Sci; 2023 Jun; 85(6):653-656. PubMed ID: 37150609
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of flomoxef and comparators against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis producing extended-spectrum β-lactamases in China.
Yang Q; Zhang H; Cheng J; Xu Z; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Shen D; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H
Int J Antimicrob Agents; 2015 May; 45(5):485-90. PubMed ID: 25600890
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities and detection performances of cefmetazole and flomoxef for extended-spectrum β-lactamase and plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae.
Matsumura Y; Yamamoto M; Nagao M; Tanaka M; Takakura S; Ichiyama S
Diagn Microbiol Infect Dis; 2016 Apr; 84(4):322-7. PubMed ID: 26782634
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Pharmacodynamic Analysis of the Oxacephem Antibiotic Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales from Dogs.
Kusumoto M; Jitsuiki M; Motegi T; Harada K
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256182
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of 16 antimicrobial agents against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in two regional hospitals in Taiwan.
Liao CH; Sheng WH; Wang JT; Sun HY; Wang HK; Hsueh PR; Chen YC; Chang SC
J Microbiol Immunol Infect; 2006 Feb; 39(1):59-66. PubMed ID: 16440125
[TBL] [Abstract][Full Text] [Related]
6. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of flomoxef against extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korea.
Jung Y; Lee SS; Song W; Kim HS; Uh Y
Diagn Microbiol Infect Dis; 2019 May; 94(1):88-92. PubMed ID: 30658867
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of ESBL/AmpC genes and specific clones among the third-generation cephalosporin-resistant Enterobacteriaceae from canine and feline clinical specimens in Japan.
Maeyama Y; Taniguchi Y; Hayashi W; Ohsaki Y; Osaka S; Koide S; Tamai K; Nagano Y; Arakawa Y; Nagano N
Vet Microbiol; 2018 Mar; 216():183-189. PubMed ID: 29519514
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
[TBL] [Abstract][Full Text] [Related]
10. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Mohanty S; Gaind R; Ranjan R; Deb M
J Infect Dev Ctries; 2009 Nov; 4(1):24-9. PubMed ID: 20130375
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
Ku YH; Chuang YC; Yu WL
J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand.
Karkaba A; Grinberg A; Benschop J; Pleydell E
N Z Vet J; 2017 Mar; 65(2):105-112. PubMed ID: 27973988
[TBL] [Abstract][Full Text] [Related]
14. In vitro efficacy of 16 antimicrobial drugs against a large collection of β-lactamase-producing isolates of extraintestinal pathogenic Escherichia coli from dogs and cats.
Shimizu T; Harada K; Tsuyuki Y; Kimura Y; Miyamoto T; Hatoya S; Hikasa Y
J Med Microbiol; 2017 Aug; 66(8):1085-1091. PubMed ID: 28749329
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic and Molecular Characterization of Antimicrobial Resistance in Klebsiella spp. Isolates from Companion Animals in Japan: Clonal Dissemination of Multidrug-Resistant Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.
Harada K; Shimizu T; Mukai Y; Kuwajima K; Sato T; Usui M; Tamura Y; Kimura Y; Miyamoto T; Tsuyuki Y; Ohki A; Kataoka Y
Front Microbiol; 2016; 7():1021. PubMed ID: 27446056
[TBL] [Abstract][Full Text] [Related]
16. High burden of ESBL- producing Klebsiella spp., Proteus mirabilis, Enterobacter cloacae and Pseudomonas aeruginosa in diagnosed cases of urinary tract infection in a Nigerian Teaching Hospital.
Adekanmbi AO; Akinlabi OC; Usidamen S; Olaposi AV; Olaniyan AB
Acta Microbiol Immunol Hung; 2022 Jun; 69(2):127-134. PubMed ID: 35895567
[TBL] [Abstract][Full Text] [Related]
17. Fecal carriage of extended-spectrum beta-lactamase and ampc beta-lactamase-producing enterobacteriaceae in a turkish community.
Hazirolan G; Mumcuoglu I; Altan G; Özmen BB; Aksu N; Karahan ZC
Niger J Clin Pract; 2018 Jan; 21(1):81-86. PubMed ID: 29411729
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses.
Dierikx CM; van Duijkeren E; Schoormans AH; van Essen-Zandbergen A; Veldman K; Kant A; Huijsdens XW; van der Zwaluw K; Wagenaar JA; Mevius DJ
J Antimicrob Chemother; 2012 Jun; 67(6):1368-74. PubMed ID: 22382469
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance profiles and genotypes of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Klebsiella pneumoniae isolated from dogs in Beijing, China.
Liu Y; Yang Y; Chen Y; Xia Z
J Glob Antimicrob Resist; 2017 Sep; 10():219-222. PubMed ID: 28735050
[TBL] [Abstract][Full Text] [Related]
20. Clonal dissemination of OXA-48-producing Enterobacter cloacae isolates from companion animals in Algeria.
Yousfi M; Touati A; Muggeo A; Mira B; Asma B; Brasme L; Guillard T; de Champs C
J Glob Antimicrob Resist; 2018 Mar; 12():187-191. PubMed ID: 29042339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
